- Walgreens puts its money where its mouth is with World AIDS Day campaign
- Walgreens launches high-impact push in support of World AIDS Day campaign
- FDA advisory committee recommends PrEP approval for Truvada
- Walgreens, Ebony encourage Americans to be 'Greater Than AIDS'
- D.C. health department creates new pharmacy network for HIV drug-assistance program
PITTSBURGH — Generic drug maker Mylan has begun commercial operations in India, focusing on drugs to treat HIV and AIDS, the company said Monday.
The company is launching 18 antiretroviral drugs for HIV/AIDS in India, which has the world's third-largest population of people with the disease, according to the National AIDS Control Organization.
"Mylan's mission is to provide the world's 7 billion people with access to high-quality medicine," Mylan CEO Heather Bresch said. "Through the initial launch in India of a broad and innovative ARV portfolio, we are taking another significant stride towards meeting that goal."